Images from European Biotech and Pharma Partnering Conference in Osaka, Japan 2016


Leave a comment

bioXclusters reinforces its pathways to the Japanese market

Japan is the second largest pharmaceutical market in the world and leader in imports of the sector. Japanese life sciences companies are in the process of globalization and need alliances with foreign companies and biotechnology institutions to develop new medicines and incorporate new technologies. To that end, Japan is a strategic market for bioXclusters metacluster alliance. In collaboration with its Japanese Gateway Osaka Bio Headquarters, and with support of the EU-Japan Centre for industrial collaboration, bioXclusters organizes a mission to Japan in October 2017, following the 2016 success.

The organized mission allows to attend the following events. 

  • BioJapan (11-13 October 2017): Asia-wide benchmark trade fair for the global biotechnology industry that will bring together key business development and licensing professionals, R&D professionals and executives from biotechnology companies. This year’s fair also includes a HealthCare management and digital health area.

Aforementioned European Biotech and Pharma Partnering Conference in Osaka offers business contacts to industry professionals who are looking for Continue reading

Advertisements
BioFM Executive Board members and bioXclusters plus partners sign the China Gateway


Leave a comment

bioXclusters plus SMEs will benefit from a Chinese Gateway through Fenglin Group

This Monday, May 15th, representatives from bioXclusters plus and Fenglin Group signed a Gateway Agreement to offer free services and guidance for SMEs in their operations in China. Services will include assistance in market access, private investment, clinical trials and soft landing packages.  Continue reading


Leave a comment

bioXclusters plus paves the way for precision medicine companies to China Market

On 15th – 16th May bioXclusters plus will carry out a China Mission, bringing clusters and companies together at the Sino European Bio Partnering (SEBP) event at a reduced rate. Following bioXclusters plus strategy, the metacluster alliance will sign an MoU with Fenglin Group in order to provide guidance, consultancy and support to European life -sciences SMEs interested in doing business in China. Continue reading


Leave a comment

A new MoU signed with South Korea – Chuncheon Bioindustry Foundation

The bioXclusters plus alliance is pleased to announce that in November 2016, it signed a new, two-year cooperation agreement with the Chuncheon Bioindustry Foundation (CBF) from South Korea. CBF is a government funded organisation, which contributes to the improvement of local and national bioindustries.

CBF provides several systematic supports for biotech business. It represents member companies and research organisations located in the Gangwon Province of South Korea which work in the fields of biotechnology, pharmacy and medical science .

For more information about CBF, please visit the CBF website by clicking here.


Leave a comment

The Mission to Japan: 60 European healthcare SMEs have participated in a very successful mission

Thanks to an exceptional and mutual collaboration between bioXclusters plus and the EU-Japan Centre, around 60 participants from nine different European countries (Austria, France, Germany, Greece, Italy, Netherlands, Spain, Sweden and UK) participated in the joint mission to Osaka and Yokohama which took place from 10th to 14th October  2016. Continue reading


1 Comment

26 European healthcare SMEs will participate in a trade mission to Japan with bioXclusters plus

The European Strategic Cluster Partnership on Personalised Healthcare, bioXclusters plus – which has joined together four leading European biotech clusters, Biocat (Catalonia), BioM (Bavaria), BioPmed (Piedmont) and Lyonbiopole (Auvergne Rhone-Alpes) – has organised a mission to Japan which will take place from 10th to 14th October 2016. This mission, which will visit Osaka and Yokohama, has been organised in collaboration with the EU Japan Centre.

The visiting delegation will be composed of representatives from the four metacluster partners and 26 SMEs from their respective regions:

2bind GmbH, 4SC AG, Ability Pharmaceuticals S.L., Apceth GmbH & Co. KG, Ascenion GmbH, Bioindustry Park Silvano Fumero SpA, Boeters &LieckCoriolis Pharma Research GmbH, CTIBiotech, CYTOO SA, FGK Clinical Research GmbH, Gams Wellness, genOway, Indicia Production, Iris Biotech GmbH, Klifovet AG, Laboratorios Rubió S.A, Laboratorios Salvat S.A., Leukocare AG, Leukos Biotech, Medigene AG, Mind the Byte S.L., Novotec, Theranexus, Thrombotargets Europe S.L., Zeclinics S.L. Continue reading


1 Comment

Announcement of the mission to Japan (Oct. 9th – 14th, 2016)

The European Strategic Cluster Partnership alliance on Personalised Healthcare, bioXclusters plus, which joins together four leading European Bio Clusters – Biocat, BioM, BioPmed and Lyonbiopole – is pleased to invite European SMEs based in its regions to join its mission to Japan. This mission has been organised in the framework of BioJapan (Oct. 12 to 14, 2016). Continue reading